w8w8
2021-11-26
Sreamed
Cardiovascular Systems Recalls Wirion Embolic Protection System
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":877218946,"tweetId":"877218946","gmtCreate":1637935093719,"gmtModify":1637935094035,"author":{"id":3575859183800572,"idStr":"3575859183800572","authorId":3575859183800572,"authorIdStr":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":60,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Sreamed</p></body></html>","htmlText":"<html><head></head><body><p>Sreamed</p></body></html>","text":"Sreamed","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/877218946","repostId":1182136836,"repostType":4,"repost":{"id":"1182136836","pubTimestamp":1637934244,"share":"https://www.laohu8.com/m/news/1182136836?lang=&edition=full","pubTime":"2021-11-26 21:44","market":"us","language":"en","title":"Cardiovascular Systems Recalls Wirion Embolic Protection System","url":"https://stock-news.laohu8.com/highlight/detail?id=1182136836","media":"Benzinga","summary":"Cardiovascular Systems Inc has commenced a voluntary recall of its WIRION Embolic Protection Systems","content":"<p><b>Cardiovascular Systems Inc</b> has commenced a voluntary recall of its WIRION Embolic Protection Systems (WIRION).</p>\n<ul>\n <li>The unused WRN-D6 models of the WIRION device are being recalled due to receiving complaints regarding filter breakage at the time of retrieval.</li>\n <li>The Company stated that the filter breakage might cause device embolism as well as additional intervention.</li>\n <li>All affected healthcare facilities were informed to stop using and return the unused WIRION devices to the Company.</li>\n <li>CSI has also notified the FDA regarding the voluntary recall.</li>\n <li>The Company has received nine filter breakage complaints so far and plans to recall all the devices currently in customer inventory.</li>\n <li>Between 22 March and 15 November, approximately 697 devices were distributed in the US.</li>\n <li>WIRION is a rapid exchange, pre-loaded filter used as an embolic protection system for removing embolic material (thrombus/debris) while performing atherectomy in calcified lesions of the lower extremities.</li>\n <li>In March, CSI acquired a portfolio of peripheral support catheters from <b>WavePoint Medical</b>.</li>\n <li>These catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to aid in lesion crossing and for guidewire exchanges.</li>\n <li>CSI expects to introduce the acquired catheters as its new ViperCross line in the first half of its fiscal year, ending on 30 June 2022.</li>\n <li><b>Price Action:</b> CSII shares closed at $23.72 on Wednesday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cardiovascular Systems Recalls Wirion Embolic Protection System</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCardiovascular Systems Recalls Wirion Embolic Protection System\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 21:44 GMT+8 <a href=https://www.benzinga.com/news/21/11/24302601/cardiovascular-systems-recalls-wirion-embolic-protection-system><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cardiovascular Systems Inc has commenced a voluntary recall of its WIRION Embolic Protection Systems (WIRION).\n\nThe unused WRN-D6 models of the WIRION device are being recalled due to receiving ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24302601/cardiovascular-systems-recalls-wirion-embolic-protection-system\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CSII":"Cardiovascular Systems"},"source_url":"https://www.benzinga.com/news/21/11/24302601/cardiovascular-systems-recalls-wirion-embolic-protection-system","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182136836","content_text":"Cardiovascular Systems Inc has commenced a voluntary recall of its WIRION Embolic Protection Systems (WIRION).\n\nThe unused WRN-D6 models of the WIRION device are being recalled due to receiving complaints regarding filter breakage at the time of retrieval.\nThe Company stated that the filter breakage might cause device embolism as well as additional intervention.\nAll affected healthcare facilities were informed to stop using and return the unused WIRION devices to the Company.\nCSI has also notified the FDA regarding the voluntary recall.\nThe Company has received nine filter breakage complaints so far and plans to recall all the devices currently in customer inventory.\nBetween 22 March and 15 November, approximately 697 devices were distributed in the US.\nWIRION is a rapid exchange, pre-loaded filter used as an embolic protection system for removing embolic material (thrombus/debris) while performing atherectomy in calcified lesions of the lower extremities.\nIn March, CSI acquired a portfolio of peripheral support catheters from WavePoint Medical.\nThese catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to aid in lesion crossing and for guidewire exchanges.\nCSI expects to introduce the acquired catheters as its new ViperCross line in the first half of its fiscal year, ending on 30 June 2022.\nPrice Action: CSII shares closed at $23.72 on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":670,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/877218946"}
精彩评论